micro dosing tirzepatide Compounded Microdose Microdosing Tirzepatide Clicks: How Many

GLP-1 therapies can be associated with gallbladder issues in some people, and rapid weight loss itself is also a known gallstone risk

Nat Chem Biol 5, 749757 (2009)

Maintain your current dose when switching

As you begin to see results, you may feel more inclined to adopt healthier lifestyle choices, such as regular exercise and mindful eating

I did my homework for about three months before pulling the trigger

In the Phase II SYNERGY-NASH trial, up to 62% of tirzepatide recipients achieved MASH resolution without worsening of fibrosis, versus 10% in the placebo group, while up to 55% saw improvement of at least one fibrosis stage without worsening of MASH, versus 30% of placebo recipients